How Rescheduling Marijuana Could Unlock Research on THC and CBD
Rescheduling marijuana research barriers would transform cannabis studies by removing DEA restrictions. This change could accelerate research on THC and CBD for medical conditions. Clinicians would gain better evidence to guide patient care.
New Congressional Bill Would Let State Agencies Provide Marijuana for Research, Backed by $150M
The new congressional bill marijuana research initiative proposes allowing state-licensed agencies to supply cannabis for studies. This could break the federal monopoly and accelerate clinical data generation. Expanding access is crucial for…
Marijuana MSOs Surge Amid 2026 Federal Reclassification Report
Marijuana federal reclassification 2026 could remove longstanding research barriers that have limited clinical trials. This shift may accelerate evidence generation for medical cannabis. Clinicians and patients should monitor these changes closely for…
New Medical Cannabis Education Platform Now Open for Clinicians and Patients
The new medical cannabis education platform offers clinicians and patients structured, evidence-based learning resources. It addresses the fragmented cannabis education landscape by providing standardized content. This platform aims to improve clinical…
Federal Bill Would Create Cannabis Research Protections – Ganjapreneur
Cannabis research protections are critical to overcoming federal scheduling conflicts that have limited scientific studies. This federal bill aims to reduce regulatory barriers and promote high-quality cannabis research. Improved protections could expand…
Cannabinoids for Depression and Anxiety? The Evidence Says Slow Down – YouTube
Current cannabinoids depression anxiety evidence shows inconsistent results with limited clinical benefit. Patients often report subjective improvements, but high-quality studies reveal modest or no effects. Clinicians should prioritize evidence-based…
Gray: Marijuana Reclassification – YouTube Insights
Marijuana reclassification impacts clinical research by easing federal restrictions and enabling more robust studies. This shift could transform cannabis medicine by expanding evidence-based practice. Understanding these impacts is crucial for clinicians…
Best CBD Gummies to Quit Smoking Reviews
This article reviews the best CBD gummies quit smoking options available today. It highlights the limited clinical evidence supporting their use for smoking cessation. Patients should consider evidence-based therapies alongside CBD gummies.
Clinical Review of 24 Week Cannabis Outcomes
This 24 week cannabis outcomes review highlights clinical evidence on CBD gummy product quality and dosing. Understanding these outcomes is essential for patient education and safe use. The focus on 24 week cannabis outcomes ensures evidence-based…
Cannabis Research: Beyond Science to Health Pathways
Cannabis research pathways offer more than scientific data; they provide a route to better health through rigorous clinical studies. Evidence-based medicine is essential in evaluating cannabis therapeutics. This focus on cannabis research pathways…